SLC6A3 and Parkinson disease: Analysis of DaTscan data in the future beyond 24 months of follow-up will be important to determine if the rate of DAT loss is similar between the two groups of PD subjects or if the individuals with ≥9 HA RC-L1s continue to exhibit a higher rate of loss.